C21 Investments Inc. (CSE:CXXI)
Breaking News - July 31, 2018
C21 Investments appoints Randy
Torcom as Vice President of Marketing
Leading Integrated Cannabis Company continues to build world-class operations
Vancouver, British Columbia -- July 31, 2018 -- C21 Investments Inc. (CSE:CXXI)
continues to build a strong management team with the appointment of Randy Torcom
as Vice President of Marketing. C21 Investments is highly focused on building
and acquiring market leading marijuana brands. C21’s vertical integration is
important for maintaining high margins, however, brand building is the future of
the industry. The addition of Torcom to the C21 team, with his marketing and
branding experience, is instrumental to the execution of the Company’s brand
building mission.
“Brand integrity and authenticity are critical for success in the cannabis
industry,” said Torcom. “C21 Investments is committed to a strong national and
international brand strategy that delivers a compelling proposition of
high-quality
products, with life-style and value delivery that consumers can have a deep and
meaningful connection with that will stand the test of time.”
Torcom has more than 18 years experience crafting innovative strategies to
introduce new product lines while enhancing brand identity and consumer
perception. Randy’s most recent experience includes his role as Vice-President
of Brand Marketing at Burton Snowboards, where he owned the brand voice and
drove competitive market positioning across multiple channels. Additionally,
Torcom oversaw the visual retail strategy, ensuring a premium aesthetic and
elevated customer experience globally across all brick and mortar locations.
Torcom will be responsible for C21 Investments products worldwide and will be
based in the Company’s Oregon operations. His appointment is effective
immediately.
“Randy is an accomplished leader with multi-faceted creative talents and a
proven track record of achieving impressive branding milestones,” said Robert
Cheney, President and Chief Executive Officer, C21 Investments. “His fresh
perspective will be invaluable as C21 Investments continues to add new brands
and products through our aggressive acquisition strategy.”
ABOUT C21 INVESTMENTS
C21 Investments Inc. (CSE – CXXI) is a vertically integrated cannabis
corporation that cultivates, processes, and distributes quality cannabis and
hemp-derived consumer products in the United States. The company has definitive
agreements to acquire cannabis companies in Oregon and Nevada, that when closed
will make C21 one of the largest public cannabis companies by revenue in the
world. C21's current and announced operations currently comprise Silver State
Relief in Nevada, as well as Phantom Farms, Swell Companies, Eco Firma Farms,
and five dispensaries in two states. These brands produce and distribute a broad
range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil and
vaporizer cartridges.
The CSE has not accepted responsibility for the adequacy or accuracy of this
release.
For more information please contact:
Graeme Harris
graeme@strategy2communications.com
+1 416 402-7050
SOURCE C21 Investments Inc.
Michael Kidd appointed Chief
Financial Officer at C21 Investments
Vancouver, British Columbia -- July 26, 2018 -- C21 Investments Inc. (CSE:CXXI)
continues to build a strong management team with the appointment of Michael Kidd
as Chief Financial Officer. A native of Vancouver with international experience,
Kidd brings an extensive background in finance with privately held firms in a
variety of industries ranging from forestry to online retailing. Kidd will
report to Robert Cheney, President and Chief Executive Officer, and his
appointment is effective immediately.

"Michael has valuable experience in operations of large assets and treasury
management," said Cheney. "His experience in multiple, diverse industries makes
him ideally qualified for a role with a high-growth firm like C21, which is
acquiring quality operators in the cannabis industry."
Kidd was most recently Chief Operating Officer and Chief Financial Officer at
E.C.S. Electrical Cable Supply Ltd., a privately held leading distributor with
operations in Canada and Dubai. Kidd was also Chief Financial Officer of
Storefront.com Online; Director of Finance for Pacific Forest Products of New
Zealand, as well as VP Finance at CITIC, an Asia-based, multi-national
investment firm with interests around the world, for its New Zealand and
Canadian operations.
"With its strong balance sheet and definitive agreements to acquire cannabis
companies in Nevada and Oregon, C21 is establishing a solid base with attractive
growth potential," said Kidd. "The cannabis industry presents tremendous
opportunity for companies that have revenue-producing assets, talented
management, and an ethical culture."
ABOUT C21 INVESTMENTS
C21 Investments Inc. (CSE – CXXI) is a vertically integrated cannabis
corporation that cultivates, processes, and distributes quality cannabis and
hemp-derived consumer products in the United States. The company has definitive
agreements to acquire cannabis companies in Oregon and Nevada, that when closed
will make C21 one of the largest public cannabis companies by revenue in the
world. C21's current and announced operations currently comprise Silver State
Relief in Nevada, as well as Phantom Farms, Swell Companies, Eco Firma Farms,
and five dispensaries in two states. These brands produce and distribute a broad
range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil and
vaporizer cartridges.
The CSE has not accepted responsibility for the adequacy or accuracy of this
release.
SOURCE C21 Investments Inc.
C21 Closes Financing for
$5,330,000 Gross Proceeds
Vancouver, British Columbia -- July 19, 2018 -- C21 Investments Inc. (CSE:CXXI)
(the "Company" or "C21") announces it has closed the private placement disclosed
in News Releases dated June 28, 2018 and July 9, 2018 for gross proceeds of
Cdn$5,330,000.
In accordance with the provisions of Subscription Agreements, on July 19, 2018
the Company issued a total of 2,132,00 0
Units at Cdn$2.50 per Unit, each Unit consisting of one common share (the
"Shares") and one-half (1/2) share purchase warrant, each whole warrant
entitling the holder to purchase one (1) additional common share (for a total of
up to 1,066,000 Warrant Shares) at Cdn$5.00 per Warrant Share on or before July
18, 2019.
The Shares, together with any Warrant Shares that may be issued on exercise of
the Warrants (except for 1,280,000 Units that were issued to consultants, and
accordingly are not subject to a hold period), will be subject to a hold period
under applicable Canadian securities laws expiring on November 20, 2018, and
will be subject to such further restrictions on resale as may apply under
applicable foreign securities laws.
As previously disclosed, proceeds raised will be used toward expenditures
required for new acquisitions currently under negotiation, and for general
working capital purposes.
ON BEHALF OF THE BOARD
SIGNED: "Keturah Nathe"
Keturah Nathe, Director
For more information contact:
Keturah Nathe Tel: (604) 336-8613
The CSE has not accepted responsibility for the adequacy or accuracy of this
release.
SOURCE C21 Investments Inc.
C21 Investments Acquires
Silver State Relief With CDN $37.5 Million of Revenue in Nevada
Vancouver, British Columbia -- July 16, 2018 -- C21 Investments Inc. (CSE:CXXI)
is pleased to announce a strategic expansion into the State of Nevada with one
of the largest investment transactions into the USA cannabis industry by any
Canadian public company to date. The acquisition (the "Acquisition") and
investment of expansion capital into Silver State Relief LLC and Silver State
Cultivation LLC (Collectively "Silver State") represents a major investment
transaction valuing the acquired vertically integrated assets in excess of
USD$50 million. This major acquisition of revenue generating assets of CDN $37.5
million trailing 12-month revenue (USD $28.5 million) is a new milestone in
C21's expansion into the USA cannabis industry. The Silver State transaction is
the first transaction in a larger plan by C21 to significantly expand
cultivation, processing, wholesale distribution of branded products and retail
operations throughout the State of Nevada. The Silver State Nevada partnership
will establish C21's competitive position in the Nevada market. C21's investment
and expansion of Silver State's operations will generate new high-quality jobs
and economic development within the State of Nevada. http://www.cxxi.ca
President and CEO of C21 Robert Cheney stated: "Our entire C21 leadership is
very excited to enter the Nevada market and looks forward to working with our
new partners at Silver State. This represents our first acquisition of an
established
and profitable, vertically integrated business with strong potential for
significant expansion on all levels, and is aligned with C21's long term growth
objectives."
Silver State Acquisition Terms
For consideration to acquire Silver State Cultivation LLC and Silver State
Relief LLC, USD$20 million cash payment paid upon closing with an additional
2,500,000 common shares to be granted upon closing.
An interest bearing (3% per annum) convertible note with a principal value of
USD$14 million with a term of 36-months from the date of closing, where the
principal amount of the note is convertible into common shares of the Company at
a price of USD$3.50 per common share of C21. The Company will have an option to
acquire the 155,000 square-foot cultivation facility, including the 8,000-square
foot retail dispensary building, located in Sparks, Nevada (the "Sparks"), for
an acquisition price of USD$16 million or 4,571, 428 common shares at a deemed
value of USD$3.50 per share.
The option to acquire the second dispensary real estate located in Fernley,
Nevada (the "Fernley") for an acquisition price of USD$750,000 for the existing
building, land and fixtures, including construction adjustments, with a total
estimated cost being approximately USD$2,175,000.
A commitment of USD$10 million allocated for the purpose of further expansion
within the State of Nevada.
The closing of the Acquisition is conditional upon due diligence and subject to
regulatory approval.
Regarding the new partnership, Sonny Newman, founder and sole owner of Silver
State commented; "My team is pleased to become part of the C21 family. The
Silver State brands and products are a strong compliment to C21's existing
business, and with the financial strength of C21 we look forward to expanding
our reach within Nevada and nationwide."
About Silver State
Silver State was one of the first two companies to receive a cannabis
cultivation, production and retail license in the State of Nevada. Silver State
cultivated and sold Nevada's first legal ounce of marijuana and the company
continues to be a leader in the Nevada industry. Silver State operates an
industrial state-of-the-art indoor cultivation and processing facility of
approximately 155,000 square feet of licensed space in Washoe County, Northern
Nevada, where there is capacity in the facility to triple current production
rates and expand revenues.
Silver State also owns two retail licenses to operate dispensaries in Nevada.
Sparks, the first dispensary is located in the city of Sparks, with a second
location scheduled to open later this year in the city of Fernley, Lyon County.
Sparks is an 8,000 square-foot "cannabis superstore" facility, located in Washoe
county, having 21 points of sale and servicing over 36,000 customers per month.
The Fernley dispensary license, is an existing licensed building and property,
located in an area experiencing rapid economic growth and housing/business
development. Fernley is currently under construction and is expected to go into
operation in the fourth quarter of 2018. This new retail location along with
expanding wholesale operations is anticipated to capture similar revenue of
Sparks, with the potential to double revenues over the coming 18 months.
Silver State Revenues
In 2017, Silver State reported approximately USD$17 million of top line revenue
and approximately USD$7 Million of pre-tax profit, a year that included less
than six months of recreational sales. In 2018 the revenue for the first six
months, as at June 30, 2018 totaled approximately USD$15 million. The 2018 full
year revenues are expected to significantly exceed 2017 revenues, with the
trailing revenues for the past 12-months totaling USD$28.5 Million (CDN $37.5
Million). The Sparks dispensary is recorded as one of the top three revenue
producing dispensaries in Nevada for the past 36-months in a row. http://www.silverstaterelief.com
About C21 Investments
C21 is a cannabis company with newly acquired operations in Oregon, USA. The
Company is in active discussions to acquire additional operations in the USA and
globally, that allows for C21 to establish a world-class, vertically integrated
cannabis company. C21's strategy is to acquire existing and successful cannabis
operations with experienced management teams in place. C21's focus is to expand
into jurisdictions where it can wholly own indoor/outdoor cultivation
operations, processing/extraction facilities, bakeries, branded products, and
retail dispensaries with a large distribution network. C21's strategy will allow
the Company to report top line revenues and afford C21 the ability to compete
aggressively in the rapid growth of the cannabis industry. http://www.cxxi.ca
ON BEHALF OF THE BOARD
SIGNED: "Robert Cheney"
Robert Cheney, CEO, President, Director
Cautionary Statement:
Disclaimer: This press release contains "forward-looking information" within the
meaning of applicable securities legislation. Forward-looking information
includes, but is not limited to, statements with respect to the Company's future
business operation, expectations of gross sales, the opinions or beliefs of
management and future business goals, statements regarding the timing and
completion of the listing on the CSE and C21's USA Acquisitions. Generally,
forward looking information can be identified by the use of forward-looking
terminology such as "plans", "expects" or "does not expect", "is expected",
"budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words and phrases or
state that certain actions, events or results "may", "could", "would", "might"
or "will be taken", "occur" or "be achieved". Forward-looking information is
subject to known and unknown risks, uncertainties and other factors that may
cause the actual results, level of activity, performance or achievements of the
Company to be materially different from those expressed or implied by such
forward-looking information, including but not limited to general business,
economic and competitive uncertainties, regulatory risks including risks related
to the expected timing of the Company's participation in the Adult Use market,
market risks, risks inherent in manufacturing operations and other risks of the
cannabis industry. Although the Company has attempted to identify important
factors that could cause actual results to differ materially from those
contained in forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can be no
assurance that such information will prove to be accurate, as actual results and
future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward looking
information. Forward-looking information is provided herein for the purpose of
presenting information about management's current expectations relating to the
future and readers are cautioned that such information may not be appropriate
for other purpose. The Company does not undertake to update any forward-looking
information, except in accordance with applicable securities laws. This Release
does not constitute an offer of securities for sale in the United States, and
such securities may not be offered or sold in the United States absent
registration or an exemption from registration or an exemption from
registration.
The CSE has not accepted responsibility for the adequacy or accuracy of this
release, and in no way has passed upon the merits of the Acquisition, nor has it
approved or disapproved the contents of this press release.
SOURCE C21 Investments Inc.
C21 Expands Oregon Operations,
Acquires Swell Companies Limited Vancouver, British Columbia
Vancouver, British Columbia -- July 9, 2018 -- C21 Investments Inc. (CSE:CXXI)
is pleased to announce a strategic partnership and investment of expansion
capital into Swell Companies Limited (the "Swell"), one of the most recognized
and respected cannabis extraction and consumer packaged goods companies in
Oregon.
Operating since 2015, Swell has demonstrated a commitment to quality, consistent
innovation, and execution at scale with some of Oregon's most recognized brands.
Swell manufactures and distributes over 50 unique SKUs, with products available
statewide in over 275 licensed retail locations. In 2017, the company shipped
over 500,000 product units within Oregon and anticipates more than doubling
product units shipped through existing sales channels in 2018.
Pursuant to the signed term sheet (the "Term Sheet"), C21 will acquire 100% of
Swell's membership units (the "Acquisition") and has agreed to invest new
capital to expand Swell's manufacturing, branded product, and wholesale
operations. The partnership will strengthen C21's competitive position in Oregon
and in nationwide through access to
Swell's highly-skilled technical expertise and established brand. This
acquisition will also support the continued growth of quality manufacturing jobs
at Swell and related Oregon businesses.
Swell manufactures, extracts, packages, and distributes all of its products from
a centrally-located 10,000-sqaure foot facility in Portland, Oregon. Swell also
operates a 5,000-square foot distribution warehouse and has expansion rights for
an additional 18,000 square feet, adjacent to the primary facility. Swell
currently employs 30 full-time industry professionals and prides itself on being
one of the first cannabis companies in Oregon to offer comprehensive benefits to
all its employees.
Commenting on the new partnership Alleh Lindquist, Founder and CEO stated, "We
believe C21 is uniquely positioned to create the right kind of vertical model —
the aggregation of quality stand-alone assets that can be strategically aligned
to harmonize the supply chain, diversify risk, build brand equity and maximize
long-term value. This is an exciting time to be joining the C21 family of
companies."
"Partnering with Swell is a significant move in our national rollout strategy,
allowing us to rapidly expand extraction and manufacturing capacity across
legalized states as well as bridgehead into fast-growing CBD and wellness
product opportunities." said Robert Cheney, C21's CEO.
i. Pursuant to the Term Sheet, C21 will be acquiring 100% of Swell membership
units a total consideration of $14.7 million USD by way of a convertible note
(the "Note") with C21 common shares (the "Shares") valued at USD$3.00 per Share
convertible into a total of 4,900,000 Shares of C21 over a 24-month period. The
Note valued at USD$3,150,000 (1,050,000 shares) is convertible on closing of the
transaction (the "Closing"). An additional amount of USD$4,200,000 (1,400,000
Shares) is convertible 18 months from the date of Closing. The remaining amount
of the Note valued at USD$7,350,000 (2,450,000 Shares) is convertible 24 months
from the date of Closing. The Note has a maximum of USD $5,000,000.00 cash
redemption value (the "Redemption Option") in the event the C21 Shares are
trading at less than CDN$3.75 per share over a period of 15 trading days date
24-months from the date of Closing. The Redemption Option, if exercised, will be
subject to reasonable notice. The Redemption Option of the Note for cash, or
Shares will be subject to rules, policies and regulations set out by the
Canadian Securities Exchange (the "CSE"), governing regulatory bodies, including
other conditions to be set for in the definitive agreement (the "Definitive
Agreement").
ii. For additional consideration, $18 million USD of earn-out shares (6 Million
Shares valued at USD$3.00 per Share) will be issued over a five-year period upon
Swell achieving certain earn-out performance targets to be defined in the
Definitive Agreement. In addition to the earn-out Shares, the unit holders of
Swell will be granted options to purchase 1,050,000 Shares of C21 at a deemed
price of CDN$2.20 per Share for a period of 24 months from Closing. All Shares
that may be issued under the terms of the Acquisition will be subject to the CSE
policies.
The deferred note conversion terms and the five-year earn-out targets are
intended to align management and shareholder interests and focus the team on
executing C21's rapid growth plan.
Closing is expected to occur in Q2 2018, conditional upon completion of due
diligence and regulatory approval.
Swell is a growing and Extraction, manufacturer and distribution in a high
growth cannabis sector of THC and CBD products within Oregon. Swell currently
produces raw oil, encapsulated and vaporizer products under the in-house brands;
Swell, Dab Society and Hood Oil, while also providing contract manufacturing and
distribution for a select group of best-in-class brands such as, Quill, OCO, and
Apothecanna. Swell is a founding board member of the Oregon Cannabis
Association, active at the state and local jurisdictional level with agency
rule-making, and further supports a variety of economic development and
community non-profit organizations. Swell's established reputation for
innovation and quality manufacturing and extraction of THC and CBD consumer
packaged goods positions the company for high potential growth in the rapid
developing US cannabis markets.
www.be-swell.com
C21 is a British Columbia based cannabis investment company with newly acquired
operations in Oregon. The company is driven by a vision to establish a
world-class, vertically integrated cannabis ecosystem and is in active
discussions to acquire additional operations across the USA and globally. C21
acquires established and profitable cannabis operations with seasoned management
in strategic markets. Sector focus areas include indoor/outdoor cultivation
operations, processing/extraction facilities, branded products, and retail
operations with existing scale. When fully-developed, the C21 portfolio will
produce strong top-line revenues with compelling underlying fundamentals,
allowing the company to compete aggressively in the rapid growth of the global
cannabis industry.
http://www.cxxi.ca
ON BEHALF OF THE BOARD
SIGNED: "Robert Cheney"
Robert Cheney, CEO, President, Director
For more information contact:
Robert Cheney Tel: (604) 336-8613
www.cxxi.ca
The CSE has not accepted responsibility for the adequacy or accuracy of this
release.
Cautionary Statement:
Disclaimer: This press release contains "forward-looking information" within the
meaning of applicable securities legislation. Forward-looking information
includes, but is not limited to, statements with respect to the Company's future
business operation, expectations of gross sales, the opinions or beliefs of
management and future business goals. Generally, forward looking information can
be identified by the use of forward-looking terminology such as "plans",
"expects" or "does not expect", "is expected", "budget", "scheduled",
"estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or
"believes", or variations of such words and phrases or state that certain
actions, events or results "may", "could", "would", "might" or "will be taken",
"occur" or "be achieved". Forward-looking information is subject to known and
unknown risks, uncertainties and other factors that may cause the actual
results, level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such forward-looking
information, including but not limited to general business, economic and
competitive uncertainties, regulatory risks including risks related to the
expected timing of the Company's participation in the Adult Use market, market
risks, risks inherent in manufacturing operations and other risks of the
cannabis industry. Although the Company has attempted to identify important
factors that could cause actual results to differ materially from those
contained in forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can be no
assurance that such information will prove to be accurate, as actual results and
future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward looking
information. Forward-looking information is provided herein for the purpose of
presenting information about management's current expectations relating to the
future and readers are cautioned that such information may not be appropriate
for other purpose. The Company does not undertake to update any forward-looking
information, except in accordance with applicable securities laws. This Release
does not constitute an offer of securities for sale in the United States, and
such securities may not be offered or sold in the United States absent
registration or an exemption from registration.
SOURCE C21 Investments Inc.
-------------------------------------------------------------------
About C21 Investments Inc.:
C21 OPERATIONS
C21 makes acquisitions and operates along the entire spectrum of the cannabis
space, capturing profit margins through the entire value chain, so to report top
line revenues and afford management the ability to fully compete aggressively in
the rapidly growing cannabis market.
C21 Investments Inc. (CSE – CXXI) is a vertically integrated cannabis
corporation focused on the cultivation, manufacturing, processing, and
distribution of quality cannabis throughout the United States, including
non-hemp derived CBD products which are distributable throughout North America
and the International markets.
VERTICAL INTEGRATION
We are an ecosystem of leading businesses in strategic markets focused on value
creation through supply chain optimization, quality manufacturing, brand
extension, and distribution and retail channels.
7 Leaf
The 7 Leaf brand opened its first dispensary location on the main transportation
route in Salem, and has developed a loyal following of roughly 2000 customers
per month.
A 2nd larger retail shop with an additional 2000 sqft is being renovated and
will open soon in a nearby Salem neighborhood currently unserved by any retail
dispensary.
OPERATIONS
Pure Green
Pure Green is a 3,000 sqft retail dispensary serving over 2500 loyal customers
per month along Portland’s “Green Mile.”.
Operating since January 2014 as a local retailer of both medical and
recreational products, Pure Green occupies the same building that once housed
Portland’s first post-prohibition liquor store.
The founders of Pure Green have been public policy advocates for cannabis
legalization for more than two decades.
EFF
Indoor Operations
The Company's impending acquisition of Eco Firma Farms Oregon, involves an
approximately 20-acre cultivation site with a building structure providing
approximately 26,000 square feet of available indoor grow, processing and office
space. The Company is acquiring a 100% interest in the business holding company,
Proudest Monkey Holdings LLC, and a 100% interest the property holding company,
Covered Marina LLC, under a put/call option lease agreement. Details of the
transaction are set out below. Initially the company will occupy the land and
premises under a lease with an option to buy.
To date several commercial indoor crop cycles have been successfully completed.
The Oregon facility is currently producing cannabis at a rate of approximately
2,400 pounds per annum. Oregon's cultivation team is led by experienced cannabis
cultivators with combined experience of over 20 years in the industry. The
Company intends to double Oregon's indoor production capacity within nine months
from the closing of the Acquisitions. Additional out door grow operations
including greenhouses and processing will also be included in the 2018 expansion
program. This increased capacity will allow for the production of cannabis oil
and the processing of branded bakery and edible products. The 2019 production is
targeted to be 5,000 to 6,000 pounds of high quality indoor flower.
Swell
Operating since 2015, Swell has demonstrated a commitment to quality, consistent
innovation, and execution at scale with some of Oregon's most recognized brands.
Swell manufactures and distributes over 50 unique SKUs, with products available
statewide in over 275 licensed retail locations. In 2017, the company shipped
over 500,000 product units within Oregon and anticipates more than doubling
product units shipped through existing sales channels in 2018.
Swell manufactures, extracts, packages, and distributes all of its products from
a centrally-located 10,000-square foot facility in Portland, Oregon. Swell also
operates a 5,000-square foot distribution warehouse and has expansion rights for
an additional 18,000 square feet, adjacent to the primary facility. Swell
currently employs 30 full-time industry professionals and prides itself on being
one of the first cannabis companies in Oregon to offer comprehensive benefits to
all its employees.
Swell is a growing and Extraction, manufacturer and distribution in a high
growth cannabis sector of THC and CBD products within Oregon. Swell currently
produces raw oil, encapsulated and vaporizer products under the in-house brands;
Swell, Dab Society and Hood Oil, while also providing contract manufacturing and
distribution for a select group of best-in-class brands such as, Quill, OCO, and
Apothecanna. Swell is a founding board member of the Oregon Cannabis
Association, active at the state and local jurisdictional level with agency
rule-making, and further supports a variety of economic development and
community non-profit organizations. Swell's established reputation for
innovation and quality manufacturing and extraction of THC and CBD consumer
packaged goods positions the company for high potential growth in the rapid
developing US cannabis markets.
Phantom Farms
Outdoor Operations
Operating in Oregon since 2008, Phantom Farms is a well-established, ubiquitous
company, with “Clean Green Certified” cannabis cultivation operations, including
expertly crafted and highly sought after branded products, which are currently
available in over 175 Oregon dispensary locations.
Phantom Farm’s outdoor operation, cultivates 80,000 square feet of “mighty
tasty” cannabis in the famous Rouge Valley, in Southern Oregon, and will undergo
further expansion of 40,000 square feet in its 2018 cultivation operations.
Indoor Operations
In addition to its outdoor operations, Phantom Farms has a 5,000-square foot,
state-of-the-art indoor facility, which includes a wholesale distribution
warehouse and an extraction laboratory located onsite. Phantom Farms currently
employs 45 full-time, highly skilled industry workers; an additional 30 skilled
laborers are employed during a harvest season. Phantom Farms sales
representatives currently cover the entire state and the wholesale distribution
operations will be synergistic with the current ECO Firma Farms cultivation
operations, leading to potential increased group sales and greater market
penetration with more brand choices for customers.
Silver State Relief
Silver State was one of the first two companies to receive a cannabis
cultivation, production and retail license in the State of Nevada. Silver State
cultivated and sold Nevada’s first legal ounce of marijuana and the company
continues to be a leader in the Nevada industry. Silver State operates an
industrial state-of-the-art indoor cultivation and processing facility of
approximately 155,000 square feet of licensed space in Washoe County, Northern
Nevada, where there is capacity in the facility to triple current production
rates and expand revenues.
Silver State also owns two retail licenses to operate dispensaries in Nevada.
Sparks, the first dispensary is located in the city of Sparks, with a second
location scheduled to open later this year in the city of Fernley, Lyon County.
Sparks is an 8,000 square-foot “cannabis superstore” facility, located in Washoe
county, having 21 points of sale and servicing over 36,000 customers per month.
The Fernley dispensary license, is an existing licensed building and property,
located in an area experiencing rapid economic growth and housing/business
development. Fernley is currently under construction and is expected to go into
operation in the fourth quarter of 2018. This new retail location along with
expanding wholesale operations is anticipated to capture similar revenue of
Sparks, with the potential to double revenues over the coming 18 months.
Silver State’s operations have been featured positively in many media outlets
over the past two years as sales and customer traffic grew at a rapid rate.
Recently Rolling Stone Magazine stated, “Reno has a dozen or so dispensaries,
including the highly rated Silver State Relief……… Silver State offers
recreational marijuana delivery and discounts for veterans, seniors and senior
veterans.” (See: ROLLING STONE: “The Rolling Stone Guide to Legal Pot: Nevada”)
Silver State Revenues
In 2017, Silver State reported approximately USD$17 million of top line revenue
and approximately USD$7 Million of pre-tax profit, a year that included less
than six months of recreational sales. In 2018 the revenue for the first six
months, as at June 30, 2018 totaled approximately USD$15 million. The 2018 full
year revenues are expected to significantly exceed 2017 revenues, with the
trailing revenues for the past 12-months totalling USD$28.5 Million (CDN $37.5
Million). The Sparks dispensary is recorded as one of the top three revenue
producing dispensaries in Nevada for the past 36-months in a row.
SOURCE: https://www.cxxi.ca/
Disclaimer
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM)
which is a third party publisher that disseminates electronic information
through multiple online media channels. FNMG's intended purposes are to deliver
market updates and news alerts issued from private and publicly trading
companies as well as providing coverage and increased awareness for companies
that issue press to the public via online newswires. FNMG and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's
market updates, news alerts and corporate profiles are NOT a solicitation or
recommendation to buy, sell or hold securities. The material in this release is
intended to be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. The companies
that are discussed in this release may or may not have approved the statements
made in this release. Information in this release is derived from a variety of
sources that may or may not include the referenced company's publicly
disseminated information. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was obtained.
While this information is believed to be reliable, such reliability cannot be
guaranteed. FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material fact in this
release. This release may contain technical inaccuracies or typographical
errors. It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member of any
financial regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high degree of
risk. FNMG is not liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. This release is not without bias, and
is considered a conflict of interest if compensation has been received by FNMG
for its dissemination. To comply with Section 17(b) of the Securities Act of
1933, FNMG shall always disclose any compensation it has received, or expects to
receive in the future, for the dissemination of the information found herein on
behalf of one or more of the companies mentioned in this release. For current
services performed FNMG has been compensated forty-nine hundred dollars for C21
Investments Inc. coverage by
a non-affiliated third party. FNMG HOLDS NO SHARES OF C21 Investments Inc.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and FNMG undertakes no obligation to update such
statements.
|